Divalproex Sodium Tablet, Delayed Release
Product Images NDC 50090-7635

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 50090-7635). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500907635)

FDA Label Image

Spl-divalproex-figure-1 (Spl Divalproex Figure 1)

Spl-divalproex-figure-1 (Spl Divalproex Figure 1)
This text appears to be a list of different figures and studies related to PBO DVPX. The mention of Study 1 and Study 2 could indicate different research studies or trials conducted using PBO DVPX. One of the studies may relate to the Young Mania Rating Scale (YMRS) and the other to the Mania Rating Scale (MRS). These could be evaluations of the effectiveness or outcomes of this medical intervention.*
FDA Label Image

Spl-divalproex-figure-2 (Spl Divalproex Figure 2)

Spl-divalproex-figure-2 (Spl Divalproex Figure 2)
This text appears to show a chart illustrating the reduction in the CPS rate (%) for patients taking DVPX compared to Placebo. The chart also includes percentages for improvement, no change, and worsening. This visualization can be used to understand the effectiveness of DVPX in reducing CPS rates compared to Placebo in a clinical setting.*
FDA Label Image

Spl-divalproex-figure-3 (Spl Divalproex Figure 3)

Spl-divalproex-figure-3 (Spl Divalproex Figure 3)
This is a figure displaying data related to patients. The figure shows a section labeled "No Change" on a scale with a percentage value. The text also mentions "Buiuasiop" and "Juawanodw".*
FDA Label Image

Spl-divalproex-figure-4 (Spl Divalproex Figure 4)

Spl-divalproex-figure-4 (Spl Divalproex Figure 4)
This text provides data on the mean 4-week migraine rates for Placebo and DVPX in Study 1 and Study 2. It is likely part of a study or research report analyzing the effectiveness of different treatments for migraines.*
FDA Label Image

Spl-divalproex-structure (Spl Divalproex Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.